Lipella Pharmaceuticals
Manufacturing · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7800 Susquehanna St Ste 505, Pittsburgh,...Phone Number
(412) 901-0315Website
www.lipella.comRevenue
<$5 MillionStock Symbol
LIPOIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Lipella Pharmaceuticals
Lipella Pharmaceuticals Inc. is a clinical stage pharmaceutical company with a focus on capital efficient therapeutic development opportunities, including the proprietary repositioning of generics for rare, morbid diseases that currently have no adequate treatments, including hemorrhagic cystitis.Explore more
Lipella Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lipella Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Lipella Pharmaceuticals recently announced quarterly report
Check out if Lipella Pharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Lipella Pharmaceuticals has new funding data
Click to see if Lipella Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Lipella Pharmaceuticals launches new products
Lipella Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Lipella Pharmaceuticals
Check if Lipella Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Lipella Pharmaceuticals
Compare insights from companies similar to Lipella Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Lipella Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Lipella Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Lipella Pharmaceuticals.
Lipella Pharmaceuticals Tech Stack
A closer look at the technologies used by Lipella Pharmaceuticals
See more technologies
Most Recent Scoops
Pain Point
Pain Point, Bankruptcy, Finance
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Pain Point
reports that current treatment options for oral lichen planus (OLP) include topical creams and gels approved for skin indications, which are not well tolerated in the mouth. Approximately 40% of diagnosed and symptomatic OLP patients are refractory to treatment, and systemic corticosteroids and immunosuppressants are used sparingly due to potential systemic toxicity.
Medical Research, Pharmaceuticals
Project
Research & Development, Pharmaceuticals
Lipella Pharmaceuticals News & Media
Pittsburgh biotech company Lipella Pharmaceuticals files for bankruptcy protection
Lipella Pharmaceuticals, a biotechnology company in Pittsburgh’s Homewood neighborhood, filed for bankruptcy protection Monday following more than two decades of developing medications that never made it to market. The drugmaker is winding down operations just 10 months after being delisted from the Nasdaq stock exchange, which choked off access toLipella Pharmaceuticals Inc. Files Voluntary Petitions for Relief Under Chapter 11
PITTSBURGH, March 30, 2026 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”), a clinical-stage biotechnology company, announced today that it filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the Western District of Pennsylvania (the “Court”). The Company intends to undergo a 363 sale process under Chapter 11 in order to maximize value for creditors.Lipella Pharmaceuticals Announces CMO Retirement - TipRanks.com
Lipella Pharmaceuticals, Inc. ( ($LIPO) ) just unveiled an announcement. On October 3, 2025, Dr. Michael Chancellor announced his retirement from Lipella Pharmaceut...Lipella Pharmaceuticals Announces Positive Final Results from Phase 2a Study of LP-10 in Oral Lichen Planus
PITTSBURGH, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq : LIPO) ("Lipella," "we," "our," or the "Company"), a clinical-stage biotechnology company transforming care with innovative mucosal delivery solutions, today announced positive final results from its completed Phase 2a multicenter, dose-ranging study evaluating LP-10, a proprietary liposomal tacrolimus oral rinse, in patients with symptomatic oral lichen planus (OLP).
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lipella Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Lipella Pharmaceuticals Inc. is a clinical stage pharmaceutical company with a focus on capital efficient therapeutic development opportunities, including the proprietary repositioning of generics for rare, morbid diseases that currently have no adequate treatments, including hemorrhagic cystitis.... Read More
